112 related articles for article (PubMed ID: 1372611)
21. Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assay.
Heijtink RA; Kruining J; Weber YA; de Man RA; Schalm SW
Hepatology; 1995 Oct; 22(4 Pt 1):1078-83. PubMed ID: 7557854
[TBL] [Abstract][Full Text] [Related]
22. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen.
Golsaz-Shirazi F; Amiri MM; Bahadori M; Bayat AA; Mohammadi H; Farid S; Maddah M; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Shokri F
Viral Immunol; 2015 Oct; 28(8):425-33. PubMed ID: 26425894
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against hepatitis B virus surface antigen: preparation and characterization.
Danielová V; Nĕmecek V; Jandejsek J; Mancal P; Viechová J; König J; Benda R; Angelisová P
J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):113-9. PubMed ID: 2723420
[TBL] [Abstract][Full Text] [Related]
24. [Anti-HBs escape mutants--implication of neutralization escape and diagnostic escape].
Okamoto H
Nihon Rinsho; 2004 Aug; 62 Suppl 8():98-105. PubMed ID: 15453295
[No Abstract] [Full Text] [Related]
25. Anti-idiotypic antibodies directed against anti-HBs among the patients with chronic hepatitis B.
Kobayashi K; Suzuki H; Ueno Y; Nagatomi R; Kanno A; Otsuki M; Toyota T
Tohoku J Exp Med; 1990 Aug; 161(4):261-71. PubMed ID: 2256100
[TBL] [Abstract][Full Text] [Related]
26. Passively acquired antibody to hepatitis B surface antigen. Pitfall in evaluating immunity to hepatitis B viral infections.
Devine P; Taswell HF; Moore SB; Gilchrist GS; Jacobson TM
Arch Pathol Lab Med; 1989 May; 113(5):529-31. PubMed ID: 2712676
[TBL] [Abstract][Full Text] [Related]
27. Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection.
Swenson PD; Escobar MR; Carithers RL; Sobieski TJ
J Clin Microbiol; 1983 Aug; 18(2):305-9. PubMed ID: 6619284
[TBL] [Abstract][Full Text] [Related]
28. Production and characterization of recombinant human anti-HBs Fab antibodies.
Maeda F; Takekoshi M; Nagatsuka Y; Aotsuka S; Tsukahara M; Ohshima A; Kido I; Ono Y; Ihara S
J Virol Methods; 2005 Aug; 127(2):141-7. PubMed ID: 15896855
[TBL] [Abstract][Full Text] [Related]
29. Anti-idiotypic humoral and cellular responses to antibody to hepatitis B surface antigen in hepatitis B viral infections.
Rath S; Bal V; Mohite BJ; Haridas V; Naik SR; Kamat SA; Zuckerman AJ; Kamat RS
Clin Exp Immunol; 1988 Sep; 73(3):360-5. PubMed ID: 3264769
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
[TBL] [Abstract][Full Text] [Related]
31. Characterization of private and cross-reactive idiotypes associated with human antibodies to hepatitis B surface antigen.
Anderson SA; Ostberg LG; Ehrlich PH; Kennedy RC
Int Immunol; 1992 Feb; 4(2):135-45. PubMed ID: 1622892
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of antibody production to hepatitis B surface antigen by interleukin 2.
Kakumu S; Fuji A; Tahara H; Yoshioka K; Sakamoto N
J Clin Lab Immunol; 1988 May; 26(1):25-7. PubMed ID: 3263506
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
35. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens.
Pasha RP; Roohi A; Shokri F
Transfus Med; 2003 Apr; 13(2):83-92. PubMed ID: 12694553
[TBL] [Abstract][Full Text] [Related]
36. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.
Shouval D; Wands JR; Zurawski VR; Isselbacher KJ; Shafritz DA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):650-4. PubMed ID: 6952217
[TBL] [Abstract][Full Text] [Related]
37. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
38. Use of an enzyme-linked immunosorbent assay for screening hybridoma antibodies against hepatitis B surface antigen.
Boniolo A; Dovis M; Matteja R
J Immunol Methods; 1982; 49(1):1-15. PubMed ID: 7061870
[TBL] [Abstract][Full Text] [Related]
39. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
